Matches in Nanopublications for { ?s ?p "[A point mutation in the promoter of the nitric oxide synthase 2 gene (NOS2), termed NOS2(Lambaréné) (NOS2-G954C), protects heterozygous carriers against severe malaria as effectively as the sickle cell trait.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP931678.RARaLMj8I6QGzj6ZObtdiNPV9tRkc00IhQn5ZvI2_jqWQ130_assertion description "[A point mutation in the promoter of the nitric oxide synthase 2 gene (NOS2), termed NOS2(Lambaréné) (NOS2-G954C), protects heterozygous carriers against severe malaria as effectively as the sickle cell trait.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931678.RARaLMj8I6QGzj6ZObtdiNPV9tRkc00IhQn5ZvI2_jqWQ130_provenance.
- NP884521.RAgeF0jm-RhaupA4Z1C3buSZhZIYhODFxao2nvX8Ks0aM130_assertion description "[A point mutation in the promoter of the nitric oxide synthase 2 gene (NOS2), termed NOS2(Lambaréné) (NOS2-G954C), protects heterozygous carriers against severe malaria as effectively as the sickle cell trait.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP884521.RAgeF0jm-RhaupA4Z1C3buSZhZIYhODFxao2nvX8Ks0aM130_provenance.
- NP867757.RAqxUGFOmh_pq9e87P0FND_EcBvtdXJffe9LuyEFVyncc130_assertion description "[A point mutation in the promoter of the nitric oxide synthase 2 gene (NOS2), termed NOS2(Lambaréné) (NOS2-G954C), protects heterozygous carriers against severe malaria as effectively as the sickle cell trait.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867757.RAqxUGFOmh_pq9e87P0FND_EcBvtdXJffe9LuyEFVyncc130_provenance.
- NP985509.RABh_IpQWz2At-VLk9VBkGlk5-ipJ2v3OzytASwNi3Kis130_assertion description "[A point mutation in the promoter of the nitric oxide synthase 2 gene (NOS2), termed NOS2(Lambaréné) (NOS2-G954C), protects heterozygous carriers against severe malaria as effectively as the sickle cell trait.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP985509.RABh_IpQWz2At-VLk9VBkGlk5-ipJ2v3OzytASwNi3Kis130_provenance.
- NP593753.RA1kDfuHljkeZaB1fgNN0PXjthR7l7uZmu8-FHTT5xrtM130_assertion description "[A point mutation in the promoter of the nitric oxide synthase 2 gene (NOS2), termed NOS2(Lambaréné) (NOS2-G954C), protects heterozygous carriers against severe malaria as effectively as the sickle cell trait.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593753.RA1kDfuHljkeZaB1fgNN0PXjthR7l7uZmu8-FHTT5xrtM130_provenance.
- NP323266.RA0SEud6K6cKUxf5i96QBbJ8IqCs0cunVbXAJjHE-3Y90130_assertion description "[A point mutation in the promoter of the nitric oxide synthase 2 gene (NOS2), termed NOS2(Lambaréné) (NOS2-G954C), protects heterozygous carriers against severe malaria as effectively as the sickle cell trait.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323266.RA0SEud6K6cKUxf5i96QBbJ8IqCs0cunVbXAJjHE-3Y90130_provenance.
- NP323264.RAEAMVuKdffyolHPdBq2pnGripC50NIgiHkl-8ylw6SJs130_assertion description "[A point mutation in the promoter of the nitric oxide synthase 2 gene (NOS2), termed NOS2(Lambaréné) (NOS2-G954C), protects heterozygous carriers against severe malaria as effectively as the sickle cell trait.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323264.RAEAMVuKdffyolHPdBq2pnGripC50NIgiHkl-8ylw6SJs130_provenance.